Subhypnotic doses of zolpidem oppose dopaminergic-induced dyskinesia in Parkinson's disease.
Identifieur interne : 000314 ( Ncbi/Merge ); précédent : 000313; suivant : 000315Subhypnotic doses of zolpidem oppose dopaminergic-induced dyskinesia in Parkinson's disease.
Auteurs : E. Růzicka [République tchèque] ; J. Roth ; R. Jech ; P. BusekSource :
- Movement disorders : official journal of the Movement Disorder Society [ 0885-3185 ] ; 2000.
English descriptors
- KwdEn :
- Dopamine Agents (administration & dosage), Dopamine Agents (adverse effects), Dose-Response Relationship, Drug, Dyskinesia, Drug-Induced (diagnosis), Dyskinesia, Drug-Induced (drug therapy), Female, GABA Agonists (administration & dosage), Humans, Levodopa (administration & dosage), Levodopa (adverse effects), Middle Aged, Parkinson Disease (drug therapy), Pyridines (administration & dosage).
- MESH :
- chemical , administration & dosage : Dopamine Agents, GABA Agonists, Levodopa, Pyridines.
- chemical , adverse effects : Dopamine Agents, Levodopa.
- diagnosis : Dyskinesia, Drug-Induced.
- drug therapy : Dyskinesia, Drug-Induced, Parkinson Disease.
- Dose-Response Relationship, Drug, Female, Humans, Middle Aged.
PubMed: 10928588
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 003F37
- to stream PubMed, to step Curation: 003F37
- to stream PubMed, to step Checkpoint: 003E70
Links to Exploration step
pubmed:10928588Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Subhypnotic doses of zolpidem oppose dopaminergic-induced dyskinesia in Parkinson's disease.</title>
<author><name sortKey="Ruzicka, E" sort="Ruzicka, E" uniqKey="Ruzicka E" first="E" last="Růzicka">E. Růzicka</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Neurology, Movement Disorders Center, Charles University, Prague, Czech Republic.</nlm:affiliation>
<country xml:lang="fr">République tchèque</country>
<wicri:regionArea>Department of Neurology, Movement Disorders Center, Charles University, Prague</wicri:regionArea>
<placeName><settlement type="city">Prague</settlement>
<region type="région" nuts="2">Bohême centrale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Roth, J" sort="Roth, J" uniqKey="Roth J" first="J" last="Roth">J. Roth</name>
</author>
<author><name sortKey="Jech, R" sort="Jech, R" uniqKey="Jech R" first="R" last="Jech">R. Jech</name>
</author>
<author><name sortKey="Busek, P" sort="Busek, P" uniqKey="Busek P" first="P" last="Busek">P. Busek</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2000">2000</date>
<idno type="RBID">pubmed:10928588</idno>
<idno type="pmid">10928588</idno>
<idno type="wicri:Area/PubMed/Corpus">003F37</idno>
<idno type="wicri:Area/PubMed/Curation">003F37</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003E70</idno>
<idno type="wicri:Area/Ncbi/Merge">000314</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Subhypnotic doses of zolpidem oppose dopaminergic-induced dyskinesia in Parkinson's disease.</title>
<author><name sortKey="Ruzicka, E" sort="Ruzicka, E" uniqKey="Ruzicka E" first="E" last="Růzicka">E. Růzicka</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Neurology, Movement Disorders Center, Charles University, Prague, Czech Republic.</nlm:affiliation>
<country xml:lang="fr">République tchèque</country>
<wicri:regionArea>Department of Neurology, Movement Disorders Center, Charles University, Prague</wicri:regionArea>
<placeName><settlement type="city">Prague</settlement>
<region type="région" nuts="2">Bohême centrale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Roth, J" sort="Roth, J" uniqKey="Roth J" first="J" last="Roth">J. Roth</name>
</author>
<author><name sortKey="Jech, R" sort="Jech, R" uniqKey="Jech R" first="R" last="Jech">R. Jech</name>
</author>
<author><name sortKey="Busek, P" sort="Busek, P" uniqKey="Busek P" first="P" last="Busek">P. Busek</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2000" type="published">2000</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Dopamine Agents (administration & dosage)</term>
<term>Dopamine Agents (adverse effects)</term>
<term>Dose-Response Relationship, Drug</term>
<term>Dyskinesia, Drug-Induced (diagnosis)</term>
<term>Dyskinesia, Drug-Induced (drug therapy)</term>
<term>Female</term>
<term>GABA Agonists (administration & dosage)</term>
<term>Humans</term>
<term>Levodopa (administration & dosage)</term>
<term>Levodopa (adverse effects)</term>
<term>Middle Aged</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Pyridines (administration & dosage)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Dopamine Agents</term>
<term>GABA Agonists</term>
<term>Levodopa</term>
<term>Pyridines</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Dopamine Agents</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Dyskinesia, Drug-Induced</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Dyskinesia, Drug-Induced</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Dose-Response Relationship, Drug</term>
<term>Female</term>
<term>Humans</term>
<term>Middle Aged</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">10928588</PMID>
<DateCreated><Year>2001</Year>
<Month>01</Month>
<Day>11</Day>
</DateCreated>
<DateCompleted><Year>2001</Year>
<Month>01</Month>
<Day>11</Day>
</DateCompleted>
<DateRevised><Year>2013</Year>
<Month>11</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0885-3185</ISSN>
<JournalIssue CitedMedium="Print"><Volume>15</Volume>
<Issue>4</Issue>
<PubDate><Year>2000</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Movement disorders : official journal of the Movement Disorder Society</Title>
<ISOAbbreviation>Mov. Disord.</ISOAbbreviation>
</Journal>
<ArticleTitle>Subhypnotic doses of zolpidem oppose dopaminergic-induced dyskinesia in Parkinson's disease.</ArticleTitle>
<Pagination><MedlinePgn>734-5</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Růzicka</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
<AffiliationInfo><Affiliation>Department of Neurology, Movement Disorders Center, Charles University, Prague, Czech Republic.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Roth</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y"><LastName>Jech</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y"><LastName>Busek</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>UNITED STATES</Country>
<MedlineTA>Mov Disord</MedlineTA>
<NlmUniqueID>8610688</NlmUniqueID>
<ISSNLinking>0885-3185</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015259">Dopamine Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018755">GABA Agonists</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011725">Pyridines</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>46627O600J</RegistryNumber>
<NameOfSubstance UI="D007980">Levodopa</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>7K383OQI23</RegistryNumber>
<NameOfSubstance UI="C049109">zolpidem</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D015259">Dopamine Agents</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000008">administration & dosage</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D004305">Dose-Response Relationship, Drug</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D004409">Dyskinesia, Drug-Induced</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D018755">GABA Agonists</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000008">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D007980">Levodopa</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000008">administration & dosage</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D010300">Parkinson Disease</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D011725">Pyridines</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000008">administration & dosage</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2000</Year>
<Month>8</Month>
<Day>6</Day>
<Hour>11</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2001</Year>
<Month>2</Month>
<Day>28</Day>
<Hour>10</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2000</Year>
<Month>8</Month>
<Day>6</Day>
<Hour>11</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">10928588</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>République tchèque</li>
</country>
<region><li>Bohême centrale</li>
</region>
<settlement><li>Prague</li>
</settlement>
</list>
<tree><noCountry><name sortKey="Busek, P" sort="Busek, P" uniqKey="Busek P" first="P" last="Busek">P. Busek</name>
<name sortKey="Jech, R" sort="Jech, R" uniqKey="Jech R" first="R" last="Jech">R. Jech</name>
<name sortKey="Roth, J" sort="Roth, J" uniqKey="Roth J" first="J" last="Roth">J. Roth</name>
</noCountry>
<country name="République tchèque"><region name="Bohême centrale"><name sortKey="Ruzicka, E" sort="Ruzicka, E" uniqKey="Ruzicka E" first="E" last="Růzicka">E. Růzicka</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000314 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 000314 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Ncbi |étape= Merge |type= RBID |clé= pubmed:10928588 |texte= Subhypnotic doses of zolpidem oppose dopaminergic-induced dyskinesia in Parkinson's disease. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:10928588" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \ | NlmPubMed2Wicri -a MovDisordV3
This area was generated with Dilib version V0.6.23. |